Patent Yard Sign in
Expired European patentEurope

Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin

EP 1011635 B1 · Applicant: ARADIGM CORPORATION

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 28, 1998 and granted November 16, 2005. A European patent lasts at most 20 years from filing, so its term ended January 28, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by July 28, 2023.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJanuary 28, 1998
PublishedJune 28, 2000
GrantedNovember 16, 2005
Term endedJanuary 28, 2018
Application numberEP 98903746
Classification (CPC)A61M15/00 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedJan 28, 1998PublishedJune 28, 2000Patent grantedNov 16, 2005Term endedJan 28, 2018

Sources & verification